Stroke:缺血性卒中及急性心肌梗死后一年危险因素控制情况的比较

2018-01-03 国际循环编辑部 国际循环

近日,Stroke发表的一项最新研究对急性缺血性卒中或急性心肌梗死(AMI)患者出院后1年的血压、血脂及血糖控制情况进行了评估与对比分析。

近日,Stroke发表的一项最新研究对急性缺血性卒中或急性心肌梗死(AMI)患者出院后1年的血压、血脂及血糖控制情况进行了评估与对比分析。

研究者印第安纳大学的Bravata DM等,对2011年75家医疗机构住院的40230例患者中2127例缺血性卒中和4169例AMI患者进行分析,比较两者发病后危险因素控制情况。结果发现,与AMI患者相比,缺血性卒中患者实现血压控制达标(<40/90 mm Hg)比例较低(64%vs.77%,P<0.0001)。广义线性混合模型分析显示,校正患者及医疗机构相关协变量后,与缺血性卒中患者相比,AMI患者的血压控制率仍较高(OR=1.39, 95% CI: 1.21~1.51);但高脂血症控制情况(LDL-C<100 mg/dl)无显著统计学差异(P=0.534)。对伴有糖尿病患者的亚组分析显示,与缺血性卒中患者相比,AMI患者的血糖控制情况(糖化血红蛋白<9%)更低(OR=0.72,95%CI: 0.54~0.96)。

鉴于血压控制是卒中预防的基石,上述研究结果提示,未来有必要积极采取措施改善卒中后的血压管理状况。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1892994, encodeId=9a13189299493, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Jan 04 18:10:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806213, encodeId=a09c1806213a8, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Aug 22 22:10:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275126, encodeId=61bd2e5126f2, content=^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Wed Jan 03 20:31:30 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275117, encodeId=f5912e511736, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Wed Jan 03 19:44:39 CST 2018, time=2018-01-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1892994, encodeId=9a13189299493, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Jan 04 18:10:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806213, encodeId=a09c1806213a8, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Aug 22 22:10:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275126, encodeId=61bd2e5126f2, content=^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Wed Jan 03 20:31:30 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275117, encodeId=f5912e511736, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Wed Jan 03 19:44:39 CST 2018, time=2018-01-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1892994, encodeId=9a13189299493, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Jan 04 18:10:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806213, encodeId=a09c1806213a8, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Aug 22 22:10:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275126, encodeId=61bd2e5126f2, content=^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Wed Jan 03 20:31:30 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275117, encodeId=f5912e511736, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Wed Jan 03 19:44:39 CST 2018, time=2018-01-03, status=1, ipAttribution=)]
    2018-01-03 wqkm

    ^_^^_^^_^

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1892994, encodeId=9a13189299493, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Jan 04 18:10:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806213, encodeId=a09c1806213a8, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Aug 22 22:10:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275126, encodeId=61bd2e5126f2, content=^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Wed Jan 03 20:31:30 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275117, encodeId=f5912e511736, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Wed Jan 03 19:44:39 CST 2018, time=2018-01-03, status=1, ipAttribution=)]
    2018-01-03 1ddf0692m34(暂无匿称)

    学习了.涨知识

    0

相关资讯

Neurology:应该拒绝痴呆患者静脉溶栓吗?

痴呆不是急性缺血性卒中溶栓的禁忌症,但是大部分溶栓研究都把80岁或90岁以上患者排除在外,当前溶栓指南对这些患者的推荐意见存在差异

Neurology:儿童和青年创伤后缺血性卒中风险分析!

由此可见,创伤后2周内发生卒中的风险升高。起病经常延迟,这为卒中预防提供了一个机会。然而,在创伤时,约有1/4的卒中患者在脑血管成像检查中没有发现血管异常。

Stroke:全谷物摄入量与缺血性卒中风险分析!

由此可见,尽管全谷类食物的总体摄入量与较低的缺血性卒中的风险无关,但全谷类冷早餐谷类食品和全麸的摄入量与较低的缺血性卒中风险显著相关。需要在其他人群中进行更多的研究来重复个别谷物食品与缺血性卒中风险之间的关联。

Stroke:组蛋白去乙酰化酶抑制剂丙戊酸钠与缺血性卒中或TIA后卒中复发风险降低相关!

这些结果表明服用HDAC抑制剂SVA可能与降低卒中复发风险相关,虽然该研究并不能排除残余混杂因素的存在。这些结果支持了HDAC9在缺血性脑卒中发病中具有重要作用,进一步评估SVA或更特异的HDAC9抑制剂将其抑制来预防缺血性脑卒中复发是很有价值的。

Stroke:缺血性卒中与砷暴露相关!

由此可见,在一般人群中砷代谢产物与缺血性脑卒中的发生呈正相关。总的来说,这些发现提示甲基化的砷在卒中发病机制中发挥着潜在的作用,对未来脑血管研究具有重要意义。

JAHA:镉、颈动脉粥样硬化与缺血性卒中发生率之间的相关性分析!

由此可见,血浆中镉浓度与缺血性卒中的发生既独立相关,又可与颈动脉斑块协同作用对其产生影响。这支持了镉促进颈动脉斑块易损性的假设,从而增加了斑块破裂和缺血性卒中的风险。